Tissue Drug Level May Hold Key to NSCLC Response - in Meeting Coverage, AACR-IASLC from MedPage Today
Medical News: Tissue Drug Level May Hold Key to NSCLC Response - in Meeting Coverage, AACR-IASLC from MedPage Today
Action Points
- This study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
- In this study, tumor levels of platinum-based chemotherapy proved to be the best predictor of response in patients with advanced non-small cell lung cancer.
- Patients whose tumors had low platinum concentrations also had a shorter time to recurrence and worse progression-free survival (PFS) and overall survival.
(Link to full text)
0 comments:
Post a Comment